There was very encouraging news this week for all men and women suffering from thinning hair, receding hair and baldness. Research scientists have stated that that great headway has been made in finding a super-drug to combat alopecia – the common hair loss complaint. Experts are now saying the progress made will lead to an all-cure treatment for male-pattern baldness in less than 5-10 years.
The Trichological Society is very enthusiastic
Mark Blake, a representative from the Trichological Society was very enthusiastic when he explained in an interview with the Daily Express that scientists know so much more about hair growth and associated complaints that future successful treatments could be facilitated through stem cell research. Already doctors in the US have begun piloting the brand new drug for alopecia which can restore hair to sufferers.
A drug without the side effects is needed
Here at Skalp Micro Pigmentation we like to keep our readers informed of any new treatments or cures in the world of hair loss. Regular readers of this blog will be aware of previous articles where we have highlighted various ways in which to halt hair loss. There are drugs currently on the market such as Monoxidil (traditionally used for Male pattern baldness and specifically anti-hypertension treatment), and Finistride (also known as Propecia) The latter can have remarkable results but it can also have some worrying side effects which are still being investigated. It is also considered to be for men. Women and children should not take it. Alopecia is a complaint which is found in both genders so there is still a strong requirement for a holistic, treatment for hair loss that has a minimum amount of side effects.
New Alopecia wonder-drug
The Lead researcher into the new Alopecia drug Ruxolitinib, Dr Raphael Clynes at the Columbia University medical Centre in New York, explained how three patients, who had moderate to severe alopecia experienced complete hair growth 5 months after starting treatment. He said ”We’ve begun testing the drug in patients, but if the drug continues to be successful and safe it will have a dramatic impact on all people with this disease”.
Mark Blake is now sure it will be only a short time before they have conquered Male Pattern Baldness even though the two complaints are quite different in their origins. Alopecia is an auto-immune disease while male pattern baldness is normally hormone driven and hereditary.
In the meantime Skalp continues to offer a perfect answer for sufferers of all types of hair loss complaints such as thinning hair, alopecia and male pattern baldness. To find out more click here